$RVPH +101% on the day on phase 2 results
$RVPG make a big BOOM on the market today with positive Phase 2 Clinical Trial Results for his Acute Schizophrenia.
Reviva Pharmaceuticals is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize next-generation therapeutics for diseases representing significant unmet medical needs. There current pipeline focuses on the central nervous system, respiratory, and metabolic diseases.
Reviva is using chemical genomics driven technology platforms and proprietary chemistry to develop new medicines.
The move is definitely related to the news on Phase 2 for this one.
Here is the link of the press release:
Check the graph of today’s move:
Here is the 30-day overview: